Count | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Haloperidol/adverse effects/*analogs & derivatives/therapeutic use | 2 |
| 6 | |
| 9 | |
| 5 | |
| 2 | |
| 21 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 2 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Haloperidol/*analogs & derivatives/chemistry/*pharmacokinetics | 1 |
| 1 | |
Haloperidol/*administration & dosage/*blood/pharmacokinetics | 1 |
| 1 | |
Haloperidol/administration & dosage/antagonists & inhibitors | 1 |
| 1 | |
| 1 | |
Haloperidol/*analogs & derivatives/*metabolism/pharmacokinetics | 1 |
| 1 | |
Haloperidol/administration & dosage/*analogs & derivatives/*pharmacology | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |